Scrip Regulatory Affairs is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Email ID
Sign me in automatically next time
About Scrip Regulatory Affairs - the leading regulatory intelligence service

What is Scrip Regulatory Affairs?

SCRIP Regulatory Affairs (SRA) is the leading provider of regulatory news, analysis, comment and practical guidance for the pharma, biotech and medtech industries. SRA helps its readers – your peers and competitors in the life science pharma/biotech/medtech industries – avoid costly regulatory mistakes and is an indispensable guide to the rules and regulations governing the development, launch and post-market surveillance of drugs and medical devices worldwide.

SRA covers: regulatory agencies and legislation, marketing application requirements and guidelines, research and development, patents and intellectual property, international harmonisation, drug/medical device safety, pharmacovigilance, pharmacoeconomics, etc. delivers up-to-the-minute news and analysis on the key regulatory, legal and policy issues facing the global pharma and medtech industries. Subscribers to Scrip Regulatory Affairs have full access to this leading website and receive daily email alerts ensuring they get precisely the news and analysis they need. In addition, subscribers receive a fortnightly ebulletin highlighting the most-read articles from the previous two weeks so they need never miss enlightening commentary and insight from our contributing regulatory affairs specialists and in-house experts.

SRA provides relevant international and independent perspective, keeping readers fully informed of the latest developments.

Take a free trial subscription - it's the perfect way for you to try our service.

Scrip Regulatory Affairs
Informa UK Ltd
Christchurch Court
10-15 Newgate Street

AP: +61 2 8705 6907
US: +1 212652 5353
UK: +44 207 551 9201

Editorial Board

Scrip Regulatory Affairs’ editorial board comprises pharmaceutical and medical device regulatory and legal affairs experts from around the world.

Maureen Kenny
Editor, SCRIP Regulatory

+44 20 7017 6982

Maureen has more than 20 years of journalistic experience in the sectors SRA covers. Maureen spent two years in New York reporting for SRA’s sister publication, SCRIP Intelligence. Maureen is also a former editor of Clinica Medtech Intelligence, another SRA sister publication, and a former acting editor of SCRIP Intelligence.

Neena Brizmohun
Deputy Editor, SCRIP
Regulatory Affairs

+44 207 017 6974

Neena has both reported on and commissioned many pieces of expert analysis on many of the major developments in the pharma and medtech regulatory arenas since she joining SRA as deputy editor in 2008. She joined from Clinica Medtech Intelligence, where she covered developments in the global medical technology industry.

Vibha Sharma
Senior Reporter, SCRIP
Regulatory Affairs

+44 0203 377 3273

Vibha joined SRA in 2010 since when she has been largely responsible for SRA’s news coverage. Vibha is responsible for much of SRA’s exclusive coverage of some of the most important topics of recent years.

Dr Anne Dupraz Poiseau
Project director, medical
devices and combination
Voisin Consulting, Boulogne,
Peter Bogaert
Covington & Burling LLP, Brussels, Belgium

Peter Bogaert heads the life sciences group in the Brussels office of Covington & Burling LLP, which he joined in 1992. Mr Bogaert has developed a pan-European practice in the regulation of pharmaceuticals, medical devices and other health products, as well as biotechnology, foods and feedingstuffs under European Community law and the national laws of the EC Member States.

Manuel Campolini
Member of the Brussels Bar
Stibbe, Brussels, Belgium

Manuel Campolini is a member of the Brussels Bar and works at national, EU and international levels in the areas of unfair competition law and intellectual property rights including patent/SPC, trademarks and data exclusivity. Within the law firm Stibbe, he is a member of the Intellectual Property and Life Sciences Group, with a practice that focuses on legal assistance, strategic advice and litigation in the pharmaceutical sector (IP, regulatory, pricing and reimbursement, promotion and advertising, clinical trials, parallel trade, etc).

Geneviève Michaux
Hunton & Williams
Brussels, Belgium

Ian Dodds-Smith
Arnold and Porter, London, UK

Ian Dodds-Smith is a partner at law firm Arnold & Porter and co-head of its food, drug and medical devices practice group, as well as head of the European product liability group. He is based in the firm's London office.

Brenton James –
Consultant in Strategic,
Regulatory Affairs in the EU,
Ascot, UK
Maarten Meulenbelt
Sidley Austin LLP, Brussels, Belgium

Maarten Meulenbelt is a partner in the Brussels office of international law firm Sidley Austin and a member of the firm's Global Life Sciences Practice and Antitrust Practice. Mr Meulenbelt focuses his practice on EU regulatory affairs, litigation and competition law issues affecting the life sciences sector in Europe.

John Lisman
Lisman Legal Life sciences
Nieuwerbrug, the Netherlands

John Lisman is an independent attorney and consultant working in the framework of Lisman Legal Life sciences B.V. He focuses on issues relating to the marketing authorisation, pricing and reimbursement of medicinal products and medical technology, both nationally and at the level of the European Union.

Dr Karen Becker
Managing director,
Translational and Regulatory
Precision for Medicine
Maryland, US

Dr Jörg Schickert
Hogan Lovells, Munich
Jörg Schickert is a partner in the Munich office of Hogan Lovells. He advises major pharmaceutical, medical devices and biotech companies on any regulatory and commercial matters of these industries.
Maria Luisa Bravo
Bayer Hispania SL, Barcelona
Gesine Bejeuhr
Berli, Germany

Catherine Defabianis
A.R.C. Pharma
Neuilly – sur –Seine, France

© 2016 Informa plc. All rights reserved.
Scrip Regulatory Affairs is part of Pharma Intelligence. Scrip Regulatory Affairs is a trading division of Informa UK Limited, a company registered in England and Wales with company number 1072954 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Informa UK Limited is part of Informa PLC. © Informa UK Limited.